New challenges for intervertebral disc treatment using regenerative medicine

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Intervertebral disc (IVD) degeneration presents complex challenges for tissue engineering therapies.
• Ambiguities in disease mechanisms and lack of consensus on preclinical models hinder clinical translation.
• Existing discussions on orthopedic disease models do not fully address the unique complexities of IVD tissue engineering.

Purpose of the Study:

• To review key factors for the clinical translation of tissue-engineered IVD technologies.
• To address the unmet clinical need and identify appropriate preclinical models for safety and efficacy testing.
• To propose standardized model systems and translational pathways for successful clinical trials.

Main Methods:

• Review of current literature on IVD tissue engineering and clinical translation.
• Analysis of challenges in preclinical model selection for safety and efficacy.
• Discussion of translational pathways, including model complexity and standardization.

Main Results:

• Recommends a tiered approach for preclinical evaluation, progressing from cell culture to small and large animal models (rat, rabbit, goat, minipig).
• Highlights the importance of models that mimic human nutritional, biomechanical, and surgical conditions.
• Stresses the critical need for standardized, reproducible experimental procedures and outcome measures.

Conclusions:

• Establishing biologic plausibility of efficacy and safety in increasingly complex models is crucial.
• Standardized and reproducible methods are essential for judging the relative efficacy of IVD therapies.
• Carefully designed clinical trials with clear patient selection and objective outcome metrics are vital for success.